| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403 |
| filingDate |
2004-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b963d952fc335692ec5282570f1d1f26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a42bdcf4ce0cd71a63630e0e9626ff2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bd18825f8a64f26fb093465e234dfe7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d868a420739711eb98d72b66ee3b79c0 |
| publicationDate |
2011-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
HN-2004000171-A |
| titleOfInvention |
PHARMACEUTICAL COMPOSITIONS USEFUL IN THE TREATMENT OF ARTERIOSCLEROSIS, DYSLIPIDEMIAS AND RELATED CONDITIONS. |
| abstract |
CURRENT SUMMARY: (THE SUMMARY WAS MODIFIED) THE PRESENT INVENTION REFERS TO PHARMACEUTICAL COMPOSITIONS CONTAINING NICOTINIC ACID OR ANOTHER NICOTINIC ACID RECEPTOR AGONIST AND AN ANTAGONIST OF THE DP RECEPTOR, SELECTED FROM THE COMBINED AGREEMENT OF THE COMBINED AGREEMENT OR COMBINED AGONISM AGONISM. PHARMACEUTICALLY ACCEPTABLE VEHICLE FOR THE TREATMENT AND PREVENTION OF ATHEROSCLEROSIS AND OTHER AFFECTIONS FERRED IN THE DESCRIPTIVE MEMORY. PREVIOUS SUMMARY: THE PRESENT INVENTION REFERS TO A METHOD FOR THE TREATMENT OF ARTERIOSCLEROSIS IN WHICH NICOTINIC ACID OR ANOTHER NICOTINIC ACID AGONIST RECEPTOR IS ADMINISTERED TO A PATIENT IN COMBINATION WITH AN ANTAGONISTIC DP RECEPTOR. THE ANTAGONISTIC DP RECEIVER IS ADMINISTERED TO REDUCE, PREVENT OR ELIMINATE THE HOTSPOT AND THE SENSATION OF WARMING THAT MAY OTHERWISE OCCUR. ADDITIONAL INFORMATION: THE COMBINATION OF NICOTINIC ACID, A DP ANTAGONIST RECEPTOR BETWEEN LAROPIPRANT AND AN INHIBITOR OF HMG-Co SUCH AS SIMVASTATIN AND ATORVASTATIN REIVINIED. |
| priorityDate |
2003-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |